HR 1478
116th Congress
House
Health
Administrative law and regulatory procedures
Canada
Congressional oversight
Department of Health and Human Services
Digestive and metabolic diseases
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Prescription drugs
Trade restrictions
User charges and fees
Affordable Insulin Act of 2019
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 1, 2019
Referred to the Subcommittee on Health.
Feb 28, 2019
Referred to the House Committee on Energy and Commerce.
Feb 28, 2019
Introduced in House
Plain-English summary
Affordable Insulin Act of 2019
This bill addresses the importation of insulin from Canada and other foreign countries.
The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain insulin from Canada. The FDA may also permit the importation of insulin from certain other countries under specified circumstances.
The bill also establishes a process for certifying licensed foreign pharmacies and foreign wholesale distributors.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2